These data indicate that in vivo chronic delivery of fluoxetine promotes beta‐cell proliferation, which, together with direct effects of fluoxetine to potentiate insulin secretion, can overcome the intrinsic insulin resistance of ob/ob mice to marginally improve glucose tolerance. The gene discussed is INS; the disease is Insulin resistance.